PMC:7473478 / 16199-16782
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T68 | 19-27 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T69 | 99-108 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T70 | 478-486 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T71 | 574-582 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T178 | 28-31 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T179 | 119-122 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T105 | 407-416 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 354 | 19-27 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 355 | 99-108 | Disease | denotes | infection | MESH:D007239 |
| 356 | 478-486 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 357 | 574-582 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T127 | 0-18 | Sentence | denotes | CONCLUDING REMARKS |
| T128 | 19-72 | Sentence | denotes | COVID-19 has invoked frenzy in individuals worldwide. |
| T129 | 73-180 | Sentence | denotes | The unceasing increase of infection and death has halted the lives of the citizens of countries everywhere. |
| T130 | 181-296 | Sentence | denotes | Hence, it is important to discover novel therapeutic platforms and productive measures without further delay (104). |
| T131 | 297-487 | Sentence | denotes | The therapies produced must be easily reproducible and available in large quantities so that enough bioactive molecules will be available for all indivi-duals who have succumbed to COVID-19. |
| T132 | 488-583 | Sentence | denotes | MSCs and MSC-Exos can be used for their immunomodulatory effects in indi-viduals with COVID-19. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32731913-32271461-8028507 | 291-294 | 32271461 | denotes | 104 |